Evidence map›Paper›PMID 27294914›Full record

ArticleInternational journal of molecular sciences2016

Protective Effect of Ginsenoside Rg1 on Hematopoietic Stem/Progenitor Cells through Attenuating Oxidative Stress and the Wnt/β-Catenin Signaling Pathway in a Mouse Model of d-Galactose-induced Aging.

Jing Li, Dachuan Cai, Xin Yao, Yanyan Zhang, Linbo Chen, Pengwei Jing, Lu Wang, Yaping Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Ginsenosides on stem cells fate specification-a novel perspective.Frontiers in cell and developmental biology · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jing LiLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. jingli2523@gmail.com.
Dachuan CaiDepartment of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China. cqmucdc@sohu.com.
Xin YaoDepartment of Pathophysiology, Chongqing Medical University, Chongqing 400016, China. moliliuxiang@aliyun.com.
Yanyan ZhangLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. cqzyi531@gmail.com.
Linbo ChenLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. cqcb9866@outlook.com.
Pengwei JingLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. xhjke0316@gmail.com.
Lu WangLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. wanglu99@sina.com.
Yaping WangLaboratory of Stem Cells and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China. ypwangcq@aliyun.com.
Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell senescence is an important and current hypothesis accounting for organismal aging, especially the hematopoietic stem cell (HSC). Ginsenoside Rg1 is the main active pharmaceutical ingredient of ginseng, which is a traditional Chinese medicine. This study explored the protective effect of ginsenoside Rg1 on Sca-1⁺ hematopoietic stem/progenitor cells (HSC/HPCs) in a mouse model of d-galactose-induced aging. The mimetic aging mouse model was induced by continuous injection of d-gal for 42 days, and the C57BL/6 mice were respectively treated with ginsenoside Rg1, Vitamin E or normal saline after 7 days of d-gal injection. Compared with those in the d-gal administration alone group, ginsenoside Rg1 protected Sca-1⁺ HSC/HPCs by decreasing SA-β-Gal and enhancing the colony forming unit-mixture (CFU-Mix), and adjusting oxidative stress indices like reactive oxygen species (ROS), total anti-oxidant (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-px) and malondialdehyde (MDA). In addition, ginsenoside Rg1 decreased β-catenin and c-Myc mRNA expression and enhanced the phosphorylation of GSK-3β. Moreover, ginsenoside Rg1 down-regulated advanced glycation end products (AGEs), 4-hydroxynonenal (4-HNE), phospho-histone H2A.X (r-H2A.X), 8-OHdG, p16(Ink4a), Rb, p21(Cip1/Waf1) and p53 in senescent Sca-1⁺ HSC/HPCs. Our findings indicated that ginsenoside Rg1 can improve the resistance of Sca-1⁺ HSC/HPCs in a mouse model of d-galactose-induced aging through the suppression of oxidative stress and excessive activation of the Wnt/β-catenin signaling pathway, and reduction of DNA damage response, p16(Ink4a)-Rb and p53-p21(Cip1/Waf1) signaling.

Indexed as

Oxidative StressWnt Signaling PathwayAgingAnimalsAntioxidantsbeta CateninGalactoseGinsenosidesGlutathione PeroxidaseGlycogen Synthase Kinase 3 betaHematopoietic Stem CellsHistonesMaleMalondialdehydeMiceMice, Inbred C57BLAntioxidantsbeta CateninGalactoseginsenoside Rg1GinsenosidesGlutathione PeroxidaseGlycogen Synthase Kinase 3 betaHistonesMalondialdehydeReactive Oxygen SpeciesSuperoxide DismutaseVitamin EVitaminscellular senescence">d-galactoseginsenoside Rg1hematopoietic stem/progenitor cell (HSC/HPC)oxidative stressWnt/β-catenin

Identifiers

PMID27294914
PMCPMC4926383
OpenAlexW2413397722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.